Search research articles
Contact Us
Filters
Showing results (41-50 of 134) with videos related to
Page
of 14
Sort By:
Scandinavian Journal of Gastroenterology
|
December 30, 2021
Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn's disease; the Sensitivity to Change (STOC) study
Adriaan Volkers, Peter Bossuyt, Jitteke de Jong, et al.
Expert Review of Clinical Pharmacology
|
September 8, 2017
Management of patients with inflammatory bowel disease and spondyloarthritis
Lieven Pouillon, Peter Bossuyt, Joke Vanderstukken, et al.
United European Gastroenterology Journal
|
June 12, 2014
Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease
Delphine Labaere, Annick Smismans, August Van Olmen, et al.
Inflammatory Bowel Diseases
|
January 12, 2024
Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study
Dahham Alsoud, João Sabino, Denis Franchimont, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 24, 2020
Risk of Late Postoperative Recurrence of Crohn's Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple Centers
Lieven Pouillon, Thomas Remen, Caroline Amicone, et al.
Inflammatory Bowel Diseases
|
November 17, 2021
Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study
Jurij Hanzel, Erwin Dreesen, Séverine Vermeire, et al.
Inflammatory Bowel Diseases
|
June 17, 2021
Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study
Jurij Hanzel, Erwin Dreesen, Séverine Vermeire, et al.
The American Journal of Gastroenterology
|
November 12, 2020
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX
Pauline Rivière, Geert D'Haens, Laurent Peyrin-Biroulet, et al.
Inflammatory Bowel Diseases
|
September 4, 2024
Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn's Disease
Julian Panés, Edouard Louis, Peter Bossuyt, et al.
Inflammatory Bowel Diseases
|
August 2, 2024
Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study
Miguel Regueiro, Monika Fischer, Peter Bossuyt, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 134) with videos related to
Sort By:
Page
of 14
Scandinavian Journal of Gastroenterology
|
December 30, 2021
Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn's disease; the Sensitivity to Change (STOC) study
Adriaan Volkers, Peter Bossuyt, Jitteke de Jong, et al.
Expert Review of Clinical Pharmacology
|
September 8, 2017
Management of patients with inflammatory bowel disease and spondyloarthritis
Lieven Pouillon, Peter Bossuyt, Joke Vanderstukken, et al.
United European Gastroenterology Journal
|
June 12, 2014
Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease
Delphine Labaere, Annick Smismans, August Van Olmen, et al.
Inflammatory Bowel Diseases
|
January 12, 2024
Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study
Dahham Alsoud, João Sabino, Denis Franchimont, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 24, 2020
Risk of Late Postoperative Recurrence of Crohn's Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple Centers
Lieven Pouillon, Thomas Remen, Caroline Amicone, et al.
Inflammatory Bowel Diseases
|
November 17, 2021
Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study
Jurij Hanzel, Erwin Dreesen, Séverine Vermeire, et al.
Inflammatory Bowel Diseases
|
June 17, 2021
Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study
Jurij Hanzel, Erwin Dreesen, Séverine Vermeire, et al.
The American Journal of Gastroenterology
|
November 12, 2020
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX
Pauline Rivière, Geert D'Haens, Laurent Peyrin-Biroulet, et al.
Inflammatory Bowel Diseases
|
September 4, 2024
Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn's Disease
Julian Panés, Edouard Louis, Peter Bossuyt, et al.
Inflammatory Bowel Diseases
|
August 2, 2024
Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study
Miguel Regueiro, Monika Fischer, Peter Bossuyt, et al.
Page
of 14